Cataract Awareness Month highlights global efforts to prevent blindness through advancements in surgical care and lens ...

The iStent infinite Trabecular Micro-Bypass System Model iS3 is for minimising IOP in those with primary open-angle glaucoma.

Kevin Choi uses AI to detect critical diseases early through retinal scans. He said AI helps in screening, but it won't ...

With more options available than ever to treat patients with glaucoma, it has become clearer that treatment needs to occur as ...

Glaucoma is the second leading cause of blindness in the U.S.A primary screening tool for glaucoma is measurement of IOP. The ...

Top Cleveland Clinic and University of Iowa eye doctors explain it's not just blurry vision or irritation—and not just any ...

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

Causes of glaucoma are many and varied. Sometimes genetics are the culprit. Other times it can be an underlying illness such as diabetes, high blood pressure, heart or thyroid disease. Stress, eye ...

Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with ...

New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...

DOI: 10.1093/pnasnexus/pgaf168 Gene editing could be used to treat millions of glaucoma patients. Glaucoma is a leading cause of blindness, characterized by high pressure inside the eye.

Nicox completed the Denali Phase 3 trial for NCX 470, targeting open-angle glaucoma and ocular hypertension. NCX 470 combines ...